• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXS20021138 酚磺乙胺氯化钠注射液 Etamsylate Injection Chemical Drugs(4) New Drug Application 2003-11-04 北京巨能亚太生命科学研究中心四平巨能药业有限公司 Certificate Issued 2004-06-11 view
CXS20021137 苦参碱葡萄糖注射液 Matrine Injection Chemical Drugs(4) New Drug Application 2003-11-04 北京巨能亚太生命科学研究中心吉林省四平巨能药业有限公司 Certificate Issued 2004-06-11 view
CXS20021136 苦参碱氯化钠注射液 Matrine Injection Chemical Drugs(4) New Drug Application 2003-11-04 北京巨能亚太生命科学研究中心吉林省四平巨能药业有限公司 Certificate Issued 2004-06-18 view
CXL20022672 盐酸舍曲林片 sertraline hydrochloride Tablet Chemical Drugs(4) New Drug Application 2002-10-29 北京巨能亚太生命科学研究中心 Beijing Juneng Asia Pacific Life Science Research Center Certificate Issued 2003-12-05 view
CXL20022671 盐酸舍曲林 sertraline hydrochloride Active ingredient Chemical Drugs(4) New Drug Application 2002-10-29 北京巨能亚太生命科学研究中心 Beijing Juneng Asia Pacific Life Science Research Center Certificate Issued 2003-12-05 view
CXL20023005 拉呋替丁片 lafutidine Tablet Chemical Drugs(2) New Drug Application 2002-11-14 北京巨能亚太生命科学研究中心 Beijing Juneng Asia Pacific Life Science Research Center Certificate Issued 2003-08-18 view
CXL20023004 拉呋替丁 lafutidine Active ingredient Chemical Drugs(2) New Drug Application 2002-11-14 北京巨能亚太生命科学研究中心 Beijing Juneng Asia Pacific Life Science Research Center Certificate Issued 2003-08-18 view
CXL20021149 依达拉奉氯化钠注射液 edaravone Injection Chemical Drugs(2) New Drug Application 2002-06-10 北京巨能亚太生命科学研究中心 Beijing Juneng Asia Pacific Life Science Research Center Approval Completed-Pending Certificated 2003-01-28 view
CXL20021148 依达拉奉 edaravone Active ingredient Chemical Drugs(2) New Drug Application 2002-06-10 北京巨能亚太生命科学研究中心 Beijing Juneng Asia Pacific Life Science Research Center Approval Completed-Pending Certificated 2003-01-28 view